Insulin resistance itself enhances lipolysis and FFA release, and elevated FFAs in obesity activate toll-like receptors (TLRs) on immune cells [24], triggering inflammatory pathways like NF-κB, which increases TNF-α production. The gene discussed is NFKB1; the disease is Insulin resistance.